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Incidence of Hypertension in Korea: 5-Year Follow-up Study
Limited data are available about the incidence of hypertension over the 5-yr in non-
hypertensive subjects. The study subjects were 1,806 subjects enrolled in a rural area of 
Daegu, Korea for a cohort study from August to November 2003. Of them, 1,287 (71.3%) 
individuals had another examination 5 yr later. To estimate the incidence of hypertension, 
730 non-hypertensive individuals (265 males; mean age = 56.6 ± 11.1 yr-old) at baseline 
examination were analyzed in this study. Hypertension was defined as either a new 
diagnosis of hypertension or self-reports of newly initiated antihypertensive treatment; 
prehypertension was if the systolic blood pressure was 120-139 mmHg and/or diastolic 
blood pressure was 80-89 mmHg. During the 5-yr follow-up, 195 (26.7%) non-
hypertensive individuals developed incident hypertension. The age-adjusted 5-yr incidence 
rates of hypertension were 22.9% (95% confidence interval [CI] = 19.9-29.0) in overall 
subjects, 22.2% (95% CI = 17.2-27.2) in men, and 24.3% (95% CI = 20.4-28.2) in 
women. The incidence rates of hypertension significantly increased with age. In the 
multivariate analysis, prehypertension (Odds ratio [OR] 2.25; P < 0.001) and older age (OR 
2.26; P = 0.010) were independent predictors for incident hypertension. In this rapidly 
aging society, population-based preventive approach to decrease blood pressure, 
particularly in subjects with prehypertension, is needed to reduce hypertension.
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ORIGINAL ARTICLE
Cardiovascular Disorders
INTRODUCTION
Hypertension is now a major public health problem that affects 
approximately one billion individuals worldwide (1). It is widely 
acknowledged that blood pressure and the prevalence of hyper-
tension increases with age in adults living in western societies 
(2, 3). Therefore, as the population ages, the prevalence of hyper-
tension will increase even more. Hypertension is a major risk 
factor for coronary heart disease, heart failure, cerebrovascular 
disease and chronic renal failure (4-6). The high incidences of 
these diseases and the high prevalence of hypertension in most 
developed and developing countries make it the single most im-
portant cause of cardiovascular morbidity and mortality (7).
  The prevalence of hypertension in various regions of the world 
has been widely reported (8-10). However, much less is known 
about the incidence of newly developed hypertension than about 
its prevalence (11-13). Asians comprise the largest ethnic group 
in the world and the fastest growing minority ethnic group with-
in the United States (US) (14, 15). The prevalence of hyperten-
sion in most Asian groups is similar to that of non-Asians (10). 
Although numerous cross-sectional studies and cohort studies 
have provided important information on hypertension preva-
lence and incidence in various ethnic groups (8-13), only a few 
studies regarding the prevalence of hypertension have been con-
ducted in Korea (16, 17). The previous studies were conducted 
more than 8 yr ago. Furthermore, previous studies were cross-
sectional studies, and the incidence of hypertension was not ad-
dressed. Accordingly, limited data is available about the inci-Lee JH, et al.  •  Incidence of Hypertension in Korea
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dences of hypertension in Korea. Therefore, the purpose of this 
study is to estimate the incidence of hypertension over 5 yr in 
non-hypertensive Koreans from the HYpertension-Diabetes 
Daegu Initiative (HYDDI) study.
MATERIALS AND METHODS
Study population
The HYDDI study is a community-based health survey conduct-
ed from August to November 2003 in a rural area, Dalseong-gun, 
in Daegu, Korea. The target population of the present study was 
the residents aged 20 yr and older living in rural area covered by 
community health primary health care posts (the basic health-
care unit in rural area) of the Dalseong-gun. According to the 
resident registration, 21,011 residents were eligible for screening. 
Two to four villages from the area covered by each primary health 
care post were randomly selected, totaling 26 villages (n = 2,680). 
Of the 2,680 candidate subjects, 1,806 subjects finally agreed to 
participate in this health survey including a complete medical 
history, anthropometric measurements, and the collection of 
fasting blood samples. All participants visited community health 
centers to take the examination. During the 5-yr follow-up, 518 
subjects died or moved out from their previous residents and 
1,287 (71.3%) individuals attended the 5-yr follow-up examina-
tion. At baseline examination, 1,034 subjects (57%) did not have 
hypertension. Of these non-hypertensive subjects, 730 (70.6%) 
had the 5-yr follow-up examination and finally included in this 
analysis. 
Questionnaires survey, measurement of anthropometric, 
and laboratory parameters
The structured questionnaires covered the personal demograph-
ic data and medical history, and family history of chronic dis-
eases. The frequency and duration of alcohol consumption and 
smoking habits, and the frequency of physical exercise were re-
corded. Alcohol consumption was classified as either a drinker, 
ex-drinker, or a non-drinker from the self-administered ques-
tionnaire. Smoking was classified as either current, ex- (not for 
at least 1 yr), or a non-smoker. Physical exercise was defined with 
the frequency of physical activity: none, 1-2 times per week, or 3 
times or more per week. Anthropometric measurements includ-
ing height, weight, waist circumferences, and hip circumferences 
were also measured by practitioners. Body weight was measured 
in light clothing, and height was measured in a standing posi-
tion. Waist circumference was measured at the midpoint be-
tween the lower rib margin and the iliac crest. Body mass index 
(BMI) was calculated as weight divided by height squared (kg/
m
2). Blood sample was drawn in the state of at least 8 hr over-
night fasting. The fasting plasma glucose and serum concentra-
tion of total cholesterol, triglyceride, and high-density lipopro-
tein cholesterol were measured by enzymatic methods using the 
Dimension AR system (Dade Behring, Inc., Deerfield, IL, USA). 
Definition of hypertension
Systolic and diastolic blood pressures were measured in the sit-
ting position using a sphygmomanometer after a 5-min rest. Two 
blood pressure readings were averaged, and it was used for anal-
yses. According to the Seventh Report of the Joint National Com-
mittee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC VII) criteria, hypertension was defined 
as systolic blood pressure  ≥ 140 mmHg and/or diastolic blood 
pressure  ≥ 90 mmHg, or current use of antihypertensive medi-
cation; prehypertension was if the systolic blood pressure was 
120 to 139 mmHg and/or diastolic blood pressure was 80 to 89 
mmHg; and normal was if the systolic blood pressure was  < 120 
mmHg and diastolic blood pressure was  < 80 mmHg. Incident 
cases of hypertension were defined as either a new diagnosis or 
a self-report of a newly initiated antihypertensive treatment.
Statistical analyses
Data are expressed as the mean ± SD for continuous variables 
and as percentages for categorical variables. Comparisons be-
tween the baseline variables were made with the Student’s t-test 
for continuous variables and the Pearson’s chi-square test for 
categorical variables. The incidence of hypertension (per 100 
persons) was calculated as the number of subjects who devel-
oped hypertension during the follow-up divided by the total num-
ber of those at risk at the baseline. The age-adjusted incidence 
rates of hypertension for each of the blood pressure groups were 
determined via the direct adjustment standardization method. 
National Census data in 2005 from the Korea National Statisti-
cal Office was used to determine the standards for the Korean 
population. Logistic regression analysis was used to calculate 
the relative risk for prehypertension associated with the devel-
opment of hypertension. For all analyses, a two-sided P < 0.05 
was considered statistically significant. Statistical analysis was 
performed using SAS software, version 9.1.
Ethics statement
This study protocol was approved by the institutional review 
board of the Kyungpook National University Hospital (No. 74005-
1541). Written informed consent was obtained from all partici-
pants.
RESULTS
According to JNC VII criteria, the crude prevalence of hyperten-
sion in subjects (n = 1,804, excluding two with missing data) who 
provided blood pressure data was 42.7% (43.9% in men and 41.9% 
in women) in 2003 (Table 1). The age-adjusted prevalence of 
hypertension was 28.0% (29.5% in men and 24.8% in women) in 
2003. Baseline characteristics of 730 non-hypertensive subjects Lee JH, et al.  •  Incidence of Hypertension in Korea
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(265 males; mean age = 56.6 ± 11.1 yr-old) are shown in Table 2. 
The prehypertension was present in 35.7% (n = 459). Prehyper-
tensive individuals were older, more likely to be male, and had 
higher systolic and diastolic blood pressure, higher body mass 
index and waist to hip ratio, and higher total cholesterol and tri-
glyceride levels.
  Table 3 shows the changes in blood pressure category of sub-
jects during the follow-up according to their baseline blood pres-
sure category. During the 5-yr follow-up, 195 (26.7%) non-hyper-
tensive subjects developed hypertension, including 45 (16.6%) 
of subjects with normal blood pressure and 150 (32.7%) of sub-
jects with prehypertension. There was no significant difference 
in the incidence rate of hypertension by gender (23.0% in men 
and 28.8% in women, P = 0.089). 
  Progression to hypertension was determined on the basis of 
an increase in systolic blood pressure alone in 90 subjects (46.2%); 
diastolic blood pressure alone in 33 (16.9%); both systolic and 
diastolic blood pressure in 35 (17.9%); and on the basis of start 
of antihypertensive agents in 37 (19.0%).
  The crude 5-yr incidence of hypertension was 26.7% (95% con-
fidence interval [CI], 23.5-30.1) in overall subjects, 23.0% (95% CI, 
18.1-28.6) in men, and 28.8% (95% CI, 24.7-33.2) in women (Ta-
ble 4). The age-adjusted 5-yr incidence of hypertension was 
22.9% (95% CI, 19.9-29.0) in overall subjects, 22.2% (95% CI, 
17.2-27.2) in men, and 24.3% (95% CI, 20.4-28.2) in women. The 
Table 1. Prevalence of hypertension according to baseline blood pressure categories
No. of persons
Prevalence of hypertension (95% CI)*
Age  < 45 yr  
(n = 252)
Age 45-54 yr  
(n = 373)
Age 55-64 yr  
(n = 524)
Age  ≥ 65 yr  
(n = 655)
Crude Age-adjusted
†
Overall (n = 1,804)   15.5 (11.2-20.5) 29.8 (25.2-34.7) 46.0 (41.7-50.4) 57.9 (54.0-61.7) 42.7 (40.4-45.0) 28.0 (24.7-31.2)
Men (n = 704)   21.9 (14.1-31.5) 32.4 (24.8-40.8) 46.3 (39.2-53.4) 56.2 (50.0-62.3) 43.9 (40.2-47.6) 29.5 (24.0-34.9)
Women (n = 1,100) 11.5 (7.0-17.6) 28.1 (22.4-34.4) 45.8 (40.3-51.4) 59.0 (53.9-63.9) 41.9 (39.0-44.9) 24.8 (20.9-28.7)
*Rates are per 100 persons; 
†Age was adjusted using the direct standardization method based on the 2005 national census obtained from the Korea National Statistical Office. 
Table 2. Baseline characteristics of study subjects
Parameters Total (n = 730) Normotensive (n = 271) Prehypertensive (n = 459) P value
Age (yr)
     < 45
   45-54
   55-64
     ≥ 65
 
112 (15.3%)
203 (27.8%)
211 (28.9%)
204 (27.9%)
 
  66 (24.4%)
  81 (29.9%)
  64 (23.6%)
  60 (22.1%)
 
  46 (10.0%)
122 (26.6%)
147 (32.0%)
144 (31.4%)
< 0.001
Male 265 (36.3%)   76 (28.0%) 189 (41.2%) < 0.001
Systolic blood pressure (mmHg)   119.8 ± 10.1 109.3 ± 5.8  125.9 ± 6.2 < 0.001
Diastolic blood pressure (mmHg)   75.8 ± 6.8   69.8 ± 5.4    79.3 ± 4.8 < 0.001
Pulse pressure (mmHg)   44.0 ± 6.9   39.5 ± 4.8    46.6 ± 6.7 < 0.001
Height (cm) 158.0 ± 8.4 157.1 ± 8.2  158.6 ± 8.6 0.017
Weight (kg)   58.1 ± 9.6   56.1 ± 9.2    59.3 ± 9.6 < 0.001
Body mass index (kg/m
2)   23.2 ± 3.0   22.7 ± 3.0    23.5 ± 3.0 0.001
Waist circumference (cm)   81.0 ± 8.6   78.8 ± 8.5    82.3 ± 8.4 < 0.001
Hip circumference (cm)   93.1 ± 5.8   92.2 ± 6.0    93.6 ± 5.6 0.002
Waist to hip ratio     0.87 ± 0.07     0.85 ± 0.06      0.88 ± 0.06 < 0.001
Drinking 200 (27.9%)   51 (19.2%) 149 (33.0%) < 0.001
Smoking 180 (25.2%)   55 (21.0%) 125 (27.7%) 0.046
Exercise 174 (24.4%)   66 (24.9%) 108 (24.2%) 0.823
Diabetes mellitus 62 (8.5%) 20 (7.4%) 42 (9.2%) 0.398
Metabolic syndrome 162 (22.3%)   37 (13.7%) 125 (27.4%) < 0.001
Fasting blood glucose (mg/dL)     95.8 ± 21.2     94.3 ± 23.6      96.7 ± 19.7 0.139
Total cholesterol (mg/dL)   194.5 ± 35.5   188.4 ± 31.5    198.2 ± 37.2 < 0.001
Triglyceride (mg/dL)     146.7 ± 110.6   132.1 ± 91.5      155.3 ± 119.7 0.003
HDL-cholesterol (mg/dL)     52.0 ± 13.0     51.8 ± 11.6      52.1 ± 13.8 0.765
Data are mean ± SD for continuous variables and percentages for categorical variables. HDL, high-density lipoprotein.
Table 3. The changes in blood pressure category on follow-up according to baseline 
blood pressure category
No. of persons by 
   BP at baseline
BP on follow-up
Normal Prehypertension Hypertension
Overall (n = 730)
   Normal (n = 271)
   Prehypertension (n = 459)
 
143 (52.8%)
102 (22.2%)
 
  83 (30.6%)
207 (45.1%)
 
  45 (16.6%)
150 (32.7%)
Men (n = 265)
   Normal (n = 76)
   Prehypertension (n = 189)
 
  38 (50.0%)
  44 (23.3%)
 
  27 (35.5%)
  95 (50.3%)
 
  11 (14.5%)
  50 (26.5%)
Women (n = 465)
   Normal (n = 195)
   Prehypertension (n = 270)
 
105 (53.8%)
  58 (21.5%)
 
  56 (28.7%)
112 (41.5%)
 
  34 (17.4%)
100 (37.0%)
BP, blood pressure.Lee JH, et al.  •  Incidence of Hypertension in Korea
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incidence rates of hypertension significantly increased with age 
(17.9% in the age of  < 45 yr, 19.7% in 45-54 yr, 27.5% in 55-64 yr, 
and 37.7% in 65 or more years; P for trend  < 0.001). The crude 
5-yr incidence rates of hypertension in normotensive subjects 
were 16.6% (14.5% in men and 17.4% in women). The age-ad-
justed 5-yr incidence rates of hypertension in normotensive sub-
jects were 14.7% (95% CI, 12.2-17.3) in overall subjects, 12.5% 
(95% CI, 8.5-16.5) in men, and 16.1% (95% CI, 12.8-19.5) in wom-
en. The crude 5-yr incidence rates of hypertension in prehyper-
tensive subjects were 32.7% (26.5% in men and 37.0% in wom-
en). The age-adjusted 5-yr incidence rates were 30.1% (95% CI, 
26.8-33.4) in overall subjects, 26.4% (95% CI, 21.1-31.6) in men, 
and 32.2% (95% CI, 27.9-36.4) in women. The incidence rate of 
systolic hypertension significantly increased with age (P for 
trend < 0.05) (Fig. 1), whereas the incidence rate of diastolic hy-
pertension significantly decreased with age (P for trend  < 0.05) 
(Fig. 2).
  In multivariate logistic regression analysis, prehypertension 
(Odds ratio [OR] 2.25; 95% CI, 1.48-3.42, P < 0.001) and older 
age (OR 2.26; 95% CI, 1.21-4.20, P = 0.010) were independent 
predictors for incident hypertension after adjustment for sex, 
BMI, waist circumference, drinking, current smoking, exercise, 
high triglyceride levels, low high density lipoprotein cholesterol 
levels, and the presence of diabetes mellitus (Table 5).
DISCUSSION
In this community-based health survey in rural area of Korea, 
the age-adjusted prevalence of hypertension was 28.0% (29.5% 
in men and 24.8% in women) in 2003. The crude 5-yr incidence 
of hypertension was 26.7% (23.0% in men, and 28.8% in wom-
en) and the incidence of hypertension increased with age. Pre-
hypertensive individuals were twice as likely to develop hyper-
tension as the normotensive individuals.
  In our study, the age-adjusted prevalence of hypertension is 
higher than 19.8% of year 1990, but similar to 28.6% of the Ansan 
study (year 1999-2000) (16, 17). In previous reports, the preva-
lence of hypertension tends to be higher in Western countries 
Table 4. Five-year incidence rates of hypertension according to baseline blood pressure categories
No. of persons by BP 
   at baseline
5-yr incidence rates of hypertension (95% CI)*
Age  < 45 yr Age 45-54 yr Age 55-64 yr Age  ≥ 65 yr Crude Age-adjusted
†
Overall (n = 730)
   Normal (n = 271)
   Prehypertension (n = 459)
  17.9 (11.3-26.2)
10.6 (4.4-20.6)
  28.3 (16.0-43.5)
  19.7 (14.5-25.9)
12.3 (6.1-21.5)
  24.6 (17.2-33.2)
  27.5 (21.6-34.0)
  21.9 (12.5-34.0)
  29.9 (22.7-38.0)
  37.7 (31.1-44.8)
  23.3 (13.4-36.0)
  43.8 (35.5-52.2)
  26.7 (23.5-30.1)
  16.6 (12.4-21.6)
  32.7 (28.4-37.2)
  22.9 (19.9-29.0)
  14.7 (12.2-17.3)
  30.1 (26.8-33.4)
Men (n = 265)
   Normal (n = 76)
   Prehypertension (n = 189)
  25.0 (11.5-43.4)
10.0 (0.3-44.5)
  31.8 (13.9-54.9)
13.4 (6.3-24.0)
12.0 (2.5-31.2)
14.3 (5.4-28.5)
  18.2 (10.3-28.6)
16.7 (3.6-41.4)
18.6 (9.7-30.9)
  33.7 (24.0-44.5)
17.4 (5.0-38.8)
  39.4 (27.6-52.2)
  23.0 (18.1-28.6)
14.5 (7.5-24.4)
  26.5 (20.3-33.3)
  22.2 (17.2-27.2)
12.5 (8.5-16.5)
  26.4 (21.1-31.6)
Women (n = 465)
   Normal (n = 195)
   Prehypertension (n = 270)
15.0 (8.0-24.7)
10.7 (4.0-21.9)
25.0 (9.8-46.7)
  22.8 (16.0-30.8)
12.5 (5.2-24.1)
  30.0 (20.3-41.3)
  32.8 (25.0-41.5)
  23.9 (12.6-38.8)
  37.5 (27.4-48.5)
  40.9 (31.8-50.4)
  27.0 (13.8-44.1)
  47.4 (36.0-59.1)
  28.8 (24.7-33.2)
  17.4 (12.4-23.5)
  37.0 (31.3-43.1)
  24.3 (20.4-28.2)
  16.1 (12.8-19.5)
  32.2 (27.9-36.4)
*Rates are per 100 persons; 
†Age was adjusted using the direct standardization method based on the 2005 national census obtained from the Korea National Statistical Office. 
BP, blood pressure.
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%
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Fig. 1. Incidence of systolic hypertension by age and gender in overall (A), normoten-
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than in Asian countries although different study populations 
and different methodologies among surveys regarding the num-
ber of blood pressure measurements and the time interval be-
tween measurements may have contributed to observed differ-
ences (8-10). Over the past decade, the prevalence of hyperten-
sion has remained stable or decreased in developed countries, 
whereas it has shown a tendency to increase in developing coun-
tries (8). A significant downward trend in the prevalence of hy-
pertension was observed in the US during 1960-1991 and Fin-
land during 1982-1997 (18, 19). However, the third Chinese na-
tional hypertension survey reported that the prevalence of hyper-
tension increased by approximately 25% during 1980-1991 (20). 
Furthermore, a recent study reported that there were no signifi-
cant cross-sectional differences between developed and devel-
oping countries in hypertension indices (10). High economic 
development, changes in lifestyle and diet, and an increase in 
the prevalence of obesity, in part, may explain the rapid increase 
in the prevalence of hypertension in Korea. Another important 
factor is an increase in life expectancy in Korea over the past 
decade. According to the US International Population Reports, 
only 18 yr (2000-2018) will be required for percent of Korean pop-
ulation aged 65 and over to rise from 7 percent (aging society) 
to 14 percent (aged society) (21). 
  Several previous epidemiological studies have evaluated the 
incidence rates of hypertension in the community (11-13). How-
ever, information on the short-term rates of development of hy-
pertension in non-hypertensive blood pressure categories is lim-
ited. The Framingham heart study has provided information on 
short-term incidence of hypertension according to JNC VI and 
the World Health Organization-International Study of Hyper-
tension blood pressure categories (13). Although the Framing-
ham heart study has been regarded as a representative US cohort 
study, there are some differences in the study period, the time-
frame for follow-up, and the age distribution of the sample com-
pared with the present study. The incidence of hypertension in 
the Framingham cohort increased with age and that the extent 
of this age-related increase depends on the initial value of blood 
pressure. Over a follow-up of 4 yr, 1,907 (19%) of 9,845 partici-
pants developed hypertension including 6% of subjects with op-
timal blood pressure, 20% of those with normal blood pressure, 
and 43% of subjects with high normal blood pressure. Hyperten-
sion incidence among participants in each of the three non-hy-
pertensive categories increased with age. However, few studies 
have been conducted in Asia and cross-national comparisons 
of incidence rates of hypertension are still limited due to the dif-
ferences in methodology. In a recent investigation, the crude 2-yr 
incidence of hypertension according to JNC VI criteria was 12.2% 
Table 5. Multivariate logistic regression analysis for incident hypertension
Variables Odds ratio
95% confidence  
interval
P value
Age (yr)
     < 45
   45-54
   55-64
     ≥ 65
 
1.0
  0.89
  1.32
  2.26
 
1.0
0.47-1.69
0.71-2.47
1.21-4.20
 
0.730
0.378
0.010
Male   0.68 0.41-1.11 0.118
Prehypertension   2.25 1.48-3.42 < 0.001
Body mass index   1.08 0.99-1.17 0.094
Waist circumference   0.99 0.97-1.03 0.782
Drinking   1.30 0.83-2.02 0.249
Smoking   0.86 0.52-1.42 0.552
Exercise   1.32 0.88-1.98 0.183
High triglyceride   1.16 0.77-1.74 0.473
Low HDL cholesterol   1.17 0.77-1.78 0.472
Diabetes mellitus   1.72 0.92-3.20 0.089
HDL, high-density lipoprotein.
(
%
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Fig. 2. Incidence of diastolic hypertension by age and gender in overall (A), normo-
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(13.0% in men and 11.6% in women) in middle-aged Korean 
adults (22). Unfortunately, however, comparison of incidence 
rate of hypertension among these studies is difficult, since the 
age-adjusted incidence rate was not reported in the previous 
studies. In the present study, the crude 5-yr incidence of hyper-
tension was 26.7% (23.0% in men and 28.8% in women). When 
the annual probability of a progression to hypertension was cal-
culated based on the assumption of the constant risks, the rate 
in the present study was 5.3%, which was higher than that in the 
Framingham heart study (4.8%) but was lower than that in mid-
dle-aged Korean adults (6.3%) (13, 22). Ratio of mortality from 
coronary heart disease in men aged 35-44 between Korea and 
the US has diminished substantially from 9 in 1985 to 2.4 in 1992 
(23). The rapid increase in coronary heart disease mortality in 
Korea could be attributed, in part, to by the high incidence rates 
of hypertension.
  In the present study, prehypertension in addition to old age 
(age > 65) were independent predictors for incident hyperten-
sion, as has been reported previously (13, 22, 24, 25). One of the 
potential reasons for high incidence of hypertension in prehy-
pertensive individuals is that risk factors for hypertension (such 
as baseline age, higher body mass index, and higher total cho-
lesterol levels) were more common in prehypertensive individ-
uals (26). These findings support the recommendation of the 
JNC VII for prehypertensive individuals, lifestyle modification 
and multiple risk factor reduction, for the Asian prehyperten-
sive individuals as well.
  This study has several potential limitations. The first limitation 
is the variation in the blood pressure measurements. The pres-
ent study was based on measurements taken during a single day. 
Incidence rates of hypertension among non-hypertensive indi-
viduals in the community are likely to vary depending on the 
variance of blood pressure measurements. Previous studies re-
ported that the incidence rates of hypertension could be differ-
ent due to repeated measurements on several occasions, instead 
of a single day of reading (27, 28). Accordingly, multiple mea-
surements obtained on two or more occasions have been rec-
ommended for assessment of blood pressure status (1). How-
ever, most epidemiological studies have adopted the standard-
ized methodologies based on measurements during a single day. 
Second, we were unable to exclude the possibility of selection 
bias. The loss to follow-up rate in this study exceeded 20%, a con-
ventional standard beyond which the potential for bias increases 
if the pattern of missing subjects was not at random (29). Final-
ly, the target population of the present study is confined to the 
residents in the rural area of Daegu City. As it is quite difficult to 
maintain a cohort in urban area, a rural area was selected for this 
cohort study. Therefore, our results could not be generalized.
  In conclusion, this study provides the first information on the 
short-term incidence rates of hypertension according to JNC 
VII criteria from a cohort study of general population in a rural 
area of Korea, which is a representative developing country in 
Asia. In this rapidly aging society, population-based preventive 
approach to decrease blood pressure, particularly in subjects 
with prehypertension, is needed to reduce hypertension.     
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Daegu Initiative Study Investigators
One thousand two hundreds eighty-seven Koreans in a rural area were examined twice with 5-yr interval. After the 5-yr follow-
up, 195 (26.7%) of the 730 non-hypertensive individuals developed incident hypertension. The age-adjusted 5-yr incidence of 
hypertension were 22.9% (22.2% in men, 24.3% in women). The incidence of hypertension significantly increased with age. In 
the multivariate analysis, prehypertension and older agewere independent predictors for incident hypertension.